The Hindu Business Line : New asthma drug from Dr Reddy's

DR Reddy's Laboratories Ltd has announced the launch of `montelukast' (generic name), a non-steroidal drug indicated for prohylaxis and treatment of asthma.

In a press release here on Wednesday, the company said it would market the product under the brand name Emlucast.

The product would be available as tablets in three strengths of 10 mg tablets for adults and 4 mg and 5 mg chewable tablets for children.

According to the company, montelukast, with its once-a-day dosage and 24-hour protection, would provide a high degree of patient compliance and preference.

The company had earlier launched Zuvair (generic name zafirlukast) during February.

Send this article to Friends by E-Mail

Stories in this Section
`Reliance man unlikely to head BSES'

Axles India to make open offer at Rs 7 per share

KIOCL aid for national park

Deveshwar is IIM-C board of governors chief

Suzuki set to take control of Maruti with 56% stake -- Rights issue renunciation almost finalised

GE Shipping forms joint venture to lease copters

Sify to merge consumer businesses

Biocon, Shantha in joint venture for human insulin

No proposal to curb regulatory powers of ICAI

Company Law advisory panel gets broadbased